Document is current
Any future updates will be listed below
-
Authors
Imianowski, Charlotte J. https://orcid.org/0000-0002-7116-7591
Chen, Qiang
Workman, Creg J. https://orcid.org/0000-0002-9964-9509
Vignali, Dario A. A. https://orcid.org/0000-0002-2771-5992
- License Information
-
More Information
Article History
Accepted: 2 May 2025
First Online: 10 June 2025
Competing interests
: D.A.A.V. and C.J.W. have patents covering LAG3, with others pending, and are entitled to a share of net income generated from licensing of these patent rights for commercial development. D.A.A.V. is a cofounder and stockholder of Novasenta, Potenza, Tizona and Trishula; a stockholder of Werewolf; has patents licensed and royalties for BMS and Novasenta; a scientific advisory board member of Werewolf, Apeximmune and T7/Imreg Bio; a consultant for BMS, Regeneron, Ono Pharma, Peptone, Avidity Partners, Third Arc Bio, Peptone, Secarna and Curio Bio; and has been provided funding from BMS and Novasenta. C.J.I. and Q.C. declare no competing interests.
